Skip to main content
 

Innovators’ Network Member Medable Secures $91M in Funding

Innovators’ Network Member Medable Secures $91M in Funding

PALO ALTO, Calif.–(BUSINESS WIRE)–Medable Inc. today announced $91 million in new funding to accelerate the life sciences industry’s shift to digital and decentralized clinical trials. The Series C funding round was led by Sapphire Ventures, with follow-on investment from existing investors GSR Ventures, PPD, Inc. (Nasdaq:PPD) and Streamlined Ventures. The funding brings Medable’s total capital raised to more than $136 million. For more, click here.

More News

  • WELL Health Partners with AliveCor to Bring AI-Powered Cardiac Monitoring and Cardiologist Oversight to Canadians

  • Noah Labs Obtains FDA Breakthrough Device Designation for its AI-Powered Voice Diagnostic for Heart Failure

  • Tabia Health Announces Its AI-Powered Care Orchestration Platform is Now a Qualified Solution on Mayo Clinic Platform, Enabling Care Workflow Transformation.